Form 4 for BIIB Biogen
Accepted 2021-07-02 00:00:00 ET · period of report 2021-07-01 · accession 0001127602-21-021266 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-02 | 2021-07-01 | BIIB | Kramer Robin | CAO | F - Tax | $348.92 | -74 | 871.35 | -8% | -$25.8K |
| D | 2021-07-02 | 2021-07-01 | BIIB | Kramer Robin | CAO | M - OptEx | $348.92 | +251 | 945.35 | +36% | +$87.6K |
| D | 2021-07-02 | 2021-07-01 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | -251 | 504 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-01 | F | D | 74 | $348.92 | 871.35 | D | — | — | (F1) Includes 102.902 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2021. |
| 2 | Common | Common Stock | 2021-07-01 | M | A | 251 | $348.92 | 945.35 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2021-07-01 | M | D | 251 | $0.00 | 504 | D | $0.00 · — to 2023-07-01 | 251 Common Stock | (F2) The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 07/01/2020. |